Related Experiment Video
Updated: Jan 6, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Development and validation of an artificial intelligence-based model for cardiovascular disease prediction using
Maryam Mahdavi1, Anoshirvan Kazemnejad2, Abbas Asosheh3
1Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Background:
This research uses machine learning (ML) models to determine significant predictive factors for CVD events in Iran, a country with high mortality rates. The study evaluates the effectiveness of deep learning and mixed-effects logistic models in predicting 10-year CVD incidence using longitudinal TLGS data.
Methods:
A total of 4,872 adults aged ≥ 30 years without a history of CVD at baseline (2006-2008) were followed until 2020. Following exclusions due to prevalent CVD or insufficient follow-up data, the final analytic sample comprised 1,942 men and 2,930 women. Baseline demographic, behavioral, and biochemical characteristics were utilized as input features. A clinical history examination was employed to identify and confirm incident CVD events, such as stroke and coronary heart disease (CHD). Using longitudinal data collected during a 10-year study period, deep learning models based on Long Short-Term Memory (LSTM) and Gated Recurrent Unit (GRU) architectures were utilized to detect variations in risk factor dynamics. The area under the receiver operating characteristic curve (AUC) was employed to assess the model's performance.
Results:
During the follow-up period, 545 participants (11.2%) experienced CVD events. In both sexes, the GRU model outperformed the LSTM model. In women, the GRU achieved an AUC of 0.739, whereas in men it achieved 0.738, in both cases outperforming LSTM. Compared with the traditional mixed-effects model, discrimination was comparable in women (GRU 0.739 vs. 0.74) and higher in men (0.738 vs. 0.70). Even though the models were restricted to 21 commonly employed clinical variables, their performance was similar to that of larger-scale studies that included hundreds of variables.
Conclusions:
Deep learning models, such as GRU, can effectively leverage longitudinal medical data to predict future cardiovascular disease events. The models achieved performance comparable to studies that used far more variables, despite relying on a limited feature set.
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
05:51Assessing the Accuracy of Fitness Smartwatch Data for Cardiovascular and Physical Activity Monitoring: A Validation Study in Digital Health
Published on: February 21, 2025
Related Concept Videos
Longitudinal Studies
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...